Because the abdominal area has significant blood flow, some experts believe the medication may reach its peak concentration in the blood slightly faster when injected there
Researchers working with intranasal peptide formulations should consider the following variables: Mucosal enzymatic activity: The nasal epithelium contains proteolytic enzymes that may degrade peptides before absorption Molecular weight constraints: Smaller peptides may absorb more efficiently
Continuing guideline updates can help clinicians to navigate the commonalities and distinguishing features among the complexity of evidence, such as the current recommendations to distinguish between ASCVD, CKD and HF settings when making treatment decisions in T2D
We want to kind of understand who these drugs are for and what we know about how they're working
Caitlin Beale, MS, RDN Tester Caitlin Beale, MS, RDN, is a registered dietitian and freelance health writer with experience in clinical nutrition, education, research, and private practice
This multifaceted approach creates a comprehensive metabolic intervention that addresses multiple aspects of appetite regulation and energy expenditure